Age median (range) | 51 (32–77) |
Sex | |
Male | 6 (46%) |
Female | 7 (54%) |
ECOG PS | |
0 | 2 (15%) |
1 | 9 (70%) |
2 | 2 (15%) |
Primary location | |
Thorax | 4 (31%) |
Abdomen | 3 (24%) |
Pelvis | 2 (15%) |
Thigh | 2 (15%) |
Others | 2 (15%) |
Prior surgery | |
Yes | 8 (62%) |
No | 5 (38%) |
Metastatic disease | |
Yes | 10 (77%) |
No | 3 (23%) |
Site of metastases | |
Lungs | 4 (31%) |
Liver | 3 (24%) |
Bone | 2 (15%) |
Intra-abdominal | 2 (15%) |
Kidney | 1 (8%) |
Disease progression | |
before pazopanib | 13 (100%) |